Avid Bioservices CDMO
$ 10.41
1.36%
Quarterly report 2024-Q2
added 09-09-2024
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Richard Hancock |
Employees in the company |
222 |
Shares |
63.2 M |
Market Cap[1] |
$ 658 M |
EBITDA (LTM) |
$ -8.77 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.